|
DQP-1105
- 品牌：MedKoo
- 產(chǎn)地：美國
- 貨號：531764
- cas：380560-89-4
- 發(fā)布日期： 2022-07-20
- 更新日期： 2024-08-12
產(chǎn)品詳請
| 產(chǎn)地 | 美國 |
| 品牌 | MedKoo |
| 貨號 | 531764 |
| 用途 | This product is for research use only, not for human or veterinary use. |
| 包裝規(guī)格 | 10.0mg; |
| CAS編號 | 380560-89-4 |
| 純度 | >98%% |
| 是否進口 | 是 |
中文名稱:5-(4-BROMOPHENYL)-3-(1,2-DIHYDRO-6-METHYL-2-OXO-4-PHENYL-3-QUINOLINYL)-4,5-DIHYDRO-G-OXO-1H-PYRAZOLE-1-BUTANOIC ACID
中文別名:1H-Pyrazole-1-butanoic acid, 5-(4-bromophenyl)-3-(1,2-dihydro-6-methyl-2-oxo-4-phenyl-3-quinolinyl)-4,5-dihydro-γ-oxo-
CAS No:380560-89-4
分子式:C29H24BrN3O4
用途:Acts as a new class of NMDA receptor antagonists with potential application in neurological disability treatment and therapy. 5-(4-BroMophenyl)-3-(1,2-dihydro-6-Methyl-2-oxo-4-phenyl-3-quinolinyl)-4,5-dihydro-γ-oxo-1H-Pyrazole-1-butanoic AcidSupplier
中文別名:1H-Pyrazole-1-butanoic acid, 5-(4-bromophenyl)-3-(1,2-dihydro-6-methyl-2-oxo-4-phenyl-3-quinolinyl)-4,5-dihydro-γ-oxo-
CAS No:380560-89-4
分子式:C29H24BrN3O4
用途:Acts as a new class of NMDA receptor antagonists with potential application in neurological disability treatment and therapy. 5-(4-BroMophenyl)-3-(1,2-dihydro-6-Methyl-2-oxo-4-phenyl-3-quinolinyl)-4,5-dihydro-γ-oxo-1H-Pyrazole-1-butanoic AcidSupplier
